NCT07222696 Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-Being
| NCT ID | NCT07222696 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Weill Medical College of Cornell University |
| Condition | Rheumatoid Arthritis (RA |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2026-01-12 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2026-01-12 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if peer coaching works to reduce levels of anxiety and/or depression in adults diagnosed with Rheumatoid Arthritis (RA). The main questions it aims to answer are: Do people with RA who complete the intervention with a peer coach have lower levels of anxiety and/or depression at 6 months from baseline? Do people with RA who complete the intervention with a peer coach have lower levels of anxiety and/or depression at 6 months compared to those in the control arm? Researchers will compare the peer coaching intervention to an active-control arm (where people without RA coach participants on general health and nutrition topics) to see if peer coaching works to reduce anxiety and/or depression. Participants will meet with a coach every week for 9 weeks and complete several surveys before, during and after the intervention
Eligibility Criteria
Inclusion Criteria: * Male or Female older than 18 years of age. * Have a diagnosis of Rheumatoid Arthritis by a rheumatologist and currently taking a Disease-Modifying Anti-rheumatic drug ( Conventional Disease-Modifying Anti-rheumatic drug and/or Biological Disease-Modifying Anti-rheumatic drug) * Have high levels of depression defined as PHQ-8 scores between 10 to 20, OR high levels of anxiety based on GAD-7 scores \> 10 * Speaks English or Spanish * Have access to the internet, a computer, and/or a smartphone * Resides or lives in any state of the US, including Puerto Rico * Willing to work with a peer coach or a coach Exclusion Criteria: * Having a rheumatic disease other than RA (e.g., psoriatic arthritis, gout, lupus) * Nursing home resident * History of dementia or severe cognitive decline * Are currently bedbound * Severe depression defined as PHQ-8 scores of \>20.
Contact & Investigator
Iris Y Navarro-Millán, MD
PRINCIPAL INVESTIGATOR
Weill Medical College of Cornell University
Frequently Asked Questions
Who can join the NCT07222696 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Rheumatoid Arthritis (RA. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07222696 currently recruiting?
Yes, NCT07222696 is actively recruiting participants. Contact the research team at yin9003@med.cornell.edu for enrollment information.
Where is the NCT07222696 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT07222696 clinical trial?
NCT07222696 is sponsored by Weill Medical College of Cornell University. The principal investigator is Iris Y Navarro-Millán, MD at Weill Medical College of Cornell University. The trial plans to enroll 250 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.